| UniProt ID | CKAP4_HUMAN | |
|---|---|---|
| UniProt AC | Q07065 | |
| Protein Name | Cytoskeleton-associated protein 4 | |
| Gene Name | CKAP4 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 602 | |
| Subcellular Localization |
Endoplasmic reticulum membrane Single-pass type II membrane protein. Cell membrane Single-pass type II membrane protein. Cytoplasm, cytoskeleton. Cytoplasm, perinuclear region. Translocates to the perinuclear region upon APF-stimulation. |
|
| Protein Description | High-affinity epithelial cell surface receptor for APF.; Mediates the anchoring of the endoplasmic reticulum to microtubules.. | |
| Protein Sequence | MPSAKQRGSKGGHGAASPSEKGAHPSGGADDVAKKPPPAPQQPPPPPAPHPQQHPQQHPQNQAHGKGGHRGGGGGGGKSSSSSSASAAAAAAAASSSASCSRRLGRALNFLFYLALVAAAAFSGWCVHHVLEEVQQVRRSHQDFSRQREELGQGLQGVEQKVQSLQATFGTFESILRSSQHKQDLTEKAVKQGESEVSRISEVLQKLQNEILKDLSDGIHVVKDARERDFTSLENTVEERLTELTKSINDNIAIFTEVQKRSQKEINDMKAKVASLEESEGNKQDLKALKEAVKEIQTSAKSREWDMEALRSTLQTMESDIYTEVRELVSLKQEQQAFKEAADTERLALQALTEKLLRSEESVSRLPEEIRRLEEELRQLKSDSHGPKEDGGFRHSEAFEALQQKSQGLDSRLQHVEDGVLSMQVASARQTESLESLLSKSQEHEQRLAALQGRLEGLGSSEADQDGLASTVRSLGETQLVLYGDVEELKRSVGELPSTVESLQKVQEQVHTLLSQDQAQAARLPPQDFLDRLSSLDNLKASVSQVEADLKMLRTAVDSLVAYSVKIETNENNLESAKGLLDDLRNDLDRLFVKVEKIHEKV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Phosphorylation | -----MPSAKQRGSK -----CCCHHHCCCC | 46.96 | 22536245 | |
| 9 | Phosphorylation | PSAKQRGSKGGHGAA CCHHHCCCCCCCCCC | 30.25 | 24719451 | |
| 17 | Phosphorylation | KGGHGAASPSEKGAH CCCCCCCCCCCCCCC | 28.55 | 30266825 | |
| 19 | Phosphorylation | GHGAASPSEKGAHPS CCCCCCCCCCCCCCC | 49.82 | 30266825 | |
| 21 | 2-Hydroxyisobutyrylation | GAASPSEKGAHPSGG CCCCCCCCCCCCCCC | 66.78 | - | |
| 21 | Acetylation | GAASPSEKGAHPSGG CCCCCCCCCCCCCCC | 66.78 | - | |
| 21 | Ubiquitination | GAASPSEKGAHPSGG CCCCCCCCCCCCCCC | 66.78 | - | |
| 26 | Phosphorylation | SEKGAHPSGGADDVA CCCCCCCCCCCCCCC | 39.74 | 29255136 | |
| 78 | Malonylation | GGGGGGGKSSSSSSA CCCCCCCCCCCCHHH | 50.90 | 26320211 | |
| 78 | Ubiquitination | GGGGGGGKSSSSSSA CCCCCCCCCCCCHHH | 50.90 | - | |
| 79 | Phosphorylation | GGGGGGKSSSSSSAS CCCCCCCCCCCHHHH | 38.43 | 30576142 | |
| 80 | Phosphorylation | GGGGGKSSSSSSASA CCCCCCCCCCHHHHH | 37.41 | 21406692 | |
| 81 | Phosphorylation | GGGGKSSSSSSASAA CCCCCCCCCHHHHHH | 41.13 | 26657352 | |
| 82 | Phosphorylation | GGGKSSSSSSASAAA CCCCCCCCHHHHHHH | 30.20 | 29978859 | |
| 83 | Phosphorylation | GGKSSSSSSASAAAA CCCCCCCHHHHHHHH | 31.69 | 29978859 | |
| 84 | Phosphorylation | GKSSSSSSASAAAAA CCCCCCHHHHHHHHH | 28.35 | 26657352 | |
| 86 | Phosphorylation | SSSSSSASAAAAAAA CCCCHHHHHHHHHHH | 22.01 | 26657352 | |
| 95 | Phosphorylation | AAAAAAASSSASCSR HHHHHHHHCCHHHHH | 21.79 | 29978859 | |
| 96 | Phosphorylation | AAAAAASSSASCSRR HHHHHHHCCHHHHHH | 25.79 | 21406692 | |
| 97 | Phosphorylation | AAAAASSSASCSRRL HHHHHHCCHHHHHHH | 23.00 | 21406692 | |
| 99 | Phosphorylation | AAASSSASCSRRLGR HHHHCCHHHHHHHHH | 17.99 | 21406692 | |
| 100 | S-nitrosylation | AASSSASCSRRLGRA HHHCCHHHHHHHHHH | 3.52 | 22178444 | |
| 100 | S-palmitoylation | AASSSASCSRRLGRA HHHCCHHHHHHHHHH | 3.52 | 29575903 | |
| 101 | Phosphorylation | ASSSASCSRRLGRAL HHCCHHHHHHHHHHH | 20.24 | 30576142 | |
| 140 | Phosphorylation | EVQQVRRSHQDFSRQ HHHHHHHHCHHHHHH | 18.22 | 20860994 | |
| 145 | Phosphorylation | RRSHQDFSRQREELG HHHCHHHHHHHHHHH | 35.47 | 20860994 | |
| 182 | 2-Hydroxyisobutyrylation | ILRSSQHKQDLTEKA HHHHCHHHHHHHHHH | 37.56 | - | |
| 188 | Ubiquitination | HKQDLTEKAVKQGES HHHHHHHHHHHHCHH | 53.93 | - | |
| 195 | Phosphorylation | KAVKQGESEVSRISE HHHHHCHHHHHHHHH | 50.55 | - | |
| 198 | Phosphorylation | KQGESEVSRISEVLQ HHCHHHHHHHHHHHH | 21.61 | - | |
| 201 | Phosphorylation | ESEVSRISEVLQKLQ HHHHHHHHHHHHHHH | 22.12 | 29449344 | |
| 206 | Ubiquitination | RISEVLQKLQNEILK HHHHHHHHHHHHHHH | 48.13 | - | |
| 213 | 2-Hydroxyisobutyrylation | KLQNEILKDLSDGIH HHHHHHHHHHHCCCE | 63.38 | - | |
| 213 | Acetylation | KLQNEILKDLSDGIH HHHHHHHHHHHCCCE | 63.38 | 26051181 | |
| 213 | Ubiquitination | KLQNEILKDLSDGIH HHHHHHHHHHHCCCE | 63.38 | 21890473 | |
| 213 (in isoform 1) | Ubiquitination | - | 63.38 | 21890473 | |
| 223 | 2-Hydroxyisobutyrylation | SDGIHVVKDARERDF HCCCEECCCHHHCCC | 44.58 | - | |
| 223 | Acetylation | SDGIHVVKDARERDF HCCCEECCCHHHCCC | 44.58 | 26051181 | |
| 223 | Malonylation | SDGIHVVKDARERDF HCCCEECCCHHHCCC | 44.58 | 26320211 | |
| 223 | Ubiquitination | SDGIHVVKDARERDF HCCCEECCCHHHCCC | 44.58 | 21906983 | |
| 223 (in isoform 1) | Ubiquitination | - | 44.58 | 21890473 | |
| 231 | Phosphorylation | DARERDFTSLENTVE CHHHCCCCCHHHHHH | 36.37 | 29255136 | |
| 232 | Phosphorylation | ARERDFTSLENTVEE HHHCCCCCHHHHHHH | 33.41 | 29255136 | |
| 236 | Phosphorylation | DFTSLENTVEERLTE CCCCHHHHHHHHHHH | 21.66 | 25850435 | |
| 247 | Phosphorylation | RLTELTKSINDNIAI HHHHHHHHHHHCCHH | 22.76 | 20446291 | |
| 256 | Phosphorylation | NDNIAIFTEVQKRSQ HHCCHHHHHHHHHCH | 29.18 | 25599653 | |
| 260 | Acetylation | AIFTEVQKRSQKEIN HHHHHHHHHCHHHHH | 60.23 | 26051181 | |
| 270 | 2-Hydroxyisobutyrylation | QKEINDMKAKVASLE HHHHHHHHHHHHHHH | 48.17 | - | |
| 270 | Acetylation | QKEINDMKAKVASLE HHHHHHHHHHHHHHH | 48.17 | 25825284 | |
| 272 | 2-Hydroxyisobutyrylation | EINDMKAKVASLEES HHHHHHHHHHHHHHC | 32.58 | - | |
| 275 | Phosphorylation | DMKAKVASLEESEGN HHHHHHHHHHHCCCC | 39.02 | 29507054 | |
| 283 | 2-Hydroxyisobutyrylation | LEESEGNKQDLKALK HHHCCCCHHHHHHHH | 56.92 | - | |
| 283 | Acetylation | LEESEGNKQDLKALK HHHCCCCHHHHHHHH | 56.92 | 26051181 | |
| 283 | Malonylation | LEESEGNKQDLKALK HHHCCCCHHHHHHHH | 56.92 | 26320211 | |
| 283 | Ubiquitination | LEESEGNKQDLKALK HHHCCCCHHHHHHHH | 56.92 | - | |
| 283 (in isoform 1) | Ubiquitination | - | 56.92 | 21890473 | |
| 287 | 2-Hydroxyisobutyrylation | EGNKQDLKALKEAVK CCCHHHHHHHHHHHH | 61.02 | - | |
| 287 | Malonylation | EGNKQDLKALKEAVK CCCHHHHHHHHHHHH | 61.02 | 26320211 | |
| 287 | Ubiquitination | EGNKQDLKALKEAVK CCCHHHHHHHHHHHH | 61.02 | - | |
| 290 | 2-Hydroxyisobutyrylation | KQDLKALKEAVKEIQ HHHHHHHHHHHHHHH | 48.78 | - | |
| 294 | Succinylation | KALKEAVKEIQTSAK HHHHHHHHHHHHHHH | 57.03 | 27452117 | |
| 301 | 2-Hydroxyisobutyrylation | KEIQTSAKSREWDME HHHHHHHHHCCCCHH | 50.22 | - | |
| 301 | Ubiquitination | KEIQTSAKSREWDME HHHHHHHHHCCCCHH | 50.22 | - | |
| 312 | Phosphorylation | WDMEALRSTLQTMES CCHHHHHHHHHHHHH | 34.03 | 18669648 | |
| 313 | Phosphorylation | DMEALRSTLQTMESD CHHHHHHHHHHHHHH | 19.22 | 21712546 | |
| 316 | Phosphorylation | ALRSTLQTMESDIYT HHHHHHHHHHHHHHH | 26.47 | 18669648 | |
| 322 | Phosphorylation | QTMESDIYTEVRELV HHHHHHHHHHHHHHH | 11.22 | 27259358 | |
| 323 | Phosphorylation | TMESDIYTEVRELVS HHHHHHHHHHHHHHH | 28.47 | - | |
| 330 | Phosphorylation | TEVRELVSLKQEQQA HHHHHHHHHHHHHHH | 42.34 | 18669648 | |
| 332 | 2-Hydroxyisobutyrylation | VRELVSLKQEQQAFK HHHHHHHHHHHHHHH | 44.26 | - | |
| 355 | 2-Hydroxyisobutyrylation | ALQALTEKLLRSEES HHHHHHHHHHCCHHH | 47.81 | - | |
| 355 | Acetylation | ALQALTEKLLRSEES HHHHHHHHHHCCHHH | 47.81 | 26051181 | |
| 355 | Ubiquitination | ALQALTEKLLRSEES HHHHHHHHHHCCHHH | 47.81 | 21890473 | |
| 355 (in isoform 1) | Ubiquitination | - | 47.81 | 21890473 | |
| 362 | Phosphorylation | KLLRSEESVSRLPEE HHHCCHHHHHHCHHH | 22.72 | 26546556 | |
| 388 | 2-Hydroxyisobutyrylation | KSDSHGPKEDGGFRH HHCCCCCCCCCCCCH | 73.38 | - | |
| 405 | 2-Hydroxyisobutyrylation | AFEALQQKSQGLDSR HHHHHHHHHCCHHHH | 31.61 | - | |
| 405 | Acetylation | AFEALQQKSQGLDSR HHHHHHHHHCCHHHH | 31.61 | 26051181 | |
| 405 | Ubiquitination | AFEALQQKSQGLDSR HHHHHHHHHCCHHHH | 31.61 | - | |
| 422 | Phosphorylation | HVEDGVLSMQVASAR HHHHCHHHHHCCCHH | 12.55 | 20068231 | |
| 427 | Phosphorylation | VLSMQVASARQTESL HHHHHCCCHHCHHHH | 25.73 | 20068231 | |
| 431 | O-linked_Glycosylation | QVASARQTESLESLL HCCCHHCHHHHHHHH | 23.22 | OGP | |
| 431 | Phosphorylation | QVASARQTESLESLL HCCCHHCHHHHHHHH | 23.22 | 23532336 | |
| 436 | Phosphorylation | RQTESLESLLSKSQE HCHHHHHHHHHCCHH | 39.65 | 21712546 | |
| 440 | Acetylation | SLESLLSKSQEHEQR HHHHHHHCCHHHHHH | 57.01 | 27452117 | |
| 460 | Phosphorylation | GRLEGLGSSEADQDG HHHCCCCCCHHHHCC | 30.01 | 29255136 | |
| 461 | Phosphorylation | RLEGLGSSEADQDGL HHCCCCCCHHHHCCH | 34.70 | 29255136 | |
| 474 | Phosphorylation | GLASTVRSLGETQLV CHHHHHHHHCCCEEE | 36.07 | 25867546 | |
| 478 | Phosphorylation | TVRSLGETQLVLYGD HHHHHCCCEEEEECC | 25.96 | 25867546 | |
| 483 | Phosphorylation | GETQLVLYGDVEELK CCCEEEEECCHHHHH | 12.10 | 25867546 | |
| 490 | Acetylation | YGDVEELKRSVGELP ECCHHHHHHHHCCCC | 46.00 | 26051181 | |
| 490 | Ubiquitination | YGDVEELKRSVGELP ECCHHHHHHHHCCCC | 46.00 | - | |
| 492 | Phosphorylation | DVEELKRSVGELPST CHHHHHHHHCCCCHH | 32.65 | 20068231 | |
| 498 | Phosphorylation | RSVGELPSTVESLQK HHHCCCCHHHHHHHH | 58.68 | 25338102 | |
| 499 | O-linked_Glycosylation | SVGELPSTVESLQKV HHCCCCHHHHHHHHH | 26.76 | OGP | |
| 499 | Phosphorylation | SVGELPSTVESLQKV HHCCCCHHHHHHHHH | 26.76 | 20068231 | |
| 502 | Phosphorylation | ELPSTVESLQKVQEQ CCCHHHHHHHHHHHH | 31.59 | 20068231 | |
| 512 | O-linked_Glycosylation | KVQEQVHTLLSQDQA HHHHHHHHHHCHHHH | 30.45 | 55826817 | |
| 515 | Phosphorylation | EQVHTLLSQDQAQAA HHHHHHHCHHHHHHH | 34.52 | 23312004 | |
| 534 | Phosphorylation | QDFLDRLSSLDNLKA HHHHHHHHHHHHHHH | 29.74 | 22817900 | |
| 535 | Phosphorylation | DFLDRLSSLDNLKAS HHHHHHHHHHHHHHH | 44.31 | 22817900 | |
| 540 | 2-Hydroxyisobutyrylation | LSSLDNLKASVSQVE HHHHHHHHHHHHHHH | 44.89 | - | |
| 540 | Ubiquitination | LSSLDNLKASVSQVE HHHHHHHHHHHHHHH | 44.89 | - | |
| 542 | O-linked_Glycosylation | SLDNLKASVSQVEAD HHHHHHHHHHHHHHH | 22.25 | OGP | |
| 542 | Phosphorylation | SLDNLKASVSQVEAD HHHHHHHHHHHHHHH | 22.25 | 21712546 | |
| 544 | Phosphorylation | DNLKASVSQVEADLK HHHHHHHHHHHHHHH | 26.47 | 21712546 | |
| 551 | Trimethylation | SQVEADLKMLRTAVD HHHHHHHHHHHHHHH | 36.11 | - | |
| 551 | Methylation | SQVEADLKMLRTAVD HHHHHHHHHHHHHHH | 36.11 | - | |
| 551 | Ubiquitination | SQVEADLKMLRTAVD HHHHHHHHHHHHHHH | 36.11 | 2189047 | |
| 551 (in isoform 1) | Ubiquitination | - | 36.11 | 21890473 | |
| 555 | O-linked_Glycosylation | ADLKMLRTAVDSLVA HHHHHHHHHHHHHHH | 27.37 | OGP | |
| 559 | Phosphorylation | MLRTAVDSLVAYSVK HHHHHHHHHHHHHEE | 20.39 | 28152594 | |
| 563 | Phosphorylation | AVDSLVAYSVKIETN HHHHHHHHHEEEECC | 13.40 | 28152594 | |
| 564 | O-linked_Glycosylation | VDSLVAYSVKIETNE HHHHHHHHEEEECCC | 13.75 | OGP | |
| 564 | Phosphorylation | VDSLVAYSVKIETNE HHHHHHHHEEEECCC | 13.75 | 28152594 | |
| 576 | Phosphorylation | TNENNLESAKGLLDD CCCCCHHHHHHHHHH | 38.15 | 21712546 | |
| 578 | 2-Hydroxyisobutyrylation | ENNLESAKGLLDDLR CCCHHHHHHHHHHHH | 60.41 | - | |
| 578 | Ubiquitination | ENNLESAKGLLDDLR CCCHHHHHHHHHHHH | 60.41 | - | |
| 590 | Methylation | DLRNDLDRLFVKVEK HHHHHHHHHHHHHHH | 37.00 | - | |
| 594 | 2-Hydroxyisobutyrylation | DLDRLFVKVEKIHEK HHHHHHHHHHHHHHC | 37.02 | - | |
| 594 | Acetylation | DLDRLFVKVEKIHEK HHHHHHHHHHHHHHC | 37.02 | 26051181 | |
| 597 | 2-Hydroxyisobutyrylation | RLFVKVEKIHEKV-- HHHHHHHHHHHCC-- | 52.96 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 232 | S | Phosphorylation | Kinase | FAM20C | Q8IXL6 | Uniprot |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 100 | C | Palmitoylation |
| 18296695 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CKAP4_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| HEPC_HUMAN | HAMP | physical | 21988832 | |
| TSNAX_HUMAN | TSNAX | physical | 21988832 | |
| NDUB7_HUMAN | NDUFB7 | physical | 21988832 | |
| MVP_HUMAN | MVP | physical | 21988832 | |
| CKAP4_HUMAN | CKAP4 | physical | 21988832 | |
| THOC7_HUMAN | THOC7 | physical | 21988832 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Palmitoylation | |
| Reference | PubMed |
| "Palmitoylation of cytoskeleton associated protein 4 by DHHC2regulates antiproliferative factor-mediated signaling."; Planey S.L., Keay S.K., Zhang C.O., Zacharias D.A.; Mol. Biol. Cell 20:1454-1463(2009). Cited for: SUBCELLULAR LOCATION, AND PALMITOYLATION AT CYS-100 BY ZDHHC2. | |
| "A reversibly palmitoylated resident protein(p63) of an ER-Golgiintermediate compartment is related to a circulatory shockresuscitation protein."; Schweizer A., Rohrer J., Jenoe P., De Maio A., Buchman T.G.,Hauri H.-P.; J. Cell Sci. 104:685-694(1993). Cited for: NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 312-326; 413-429 AND491-504, SUBCELLULAR LOCATION, AND PALMITOYLATION. | |
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-312; THR-316 ANDSER-330, AND MASS SPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17, AND MASSSPECTROMETRY. | |
| "Phosphorylation controls CLIMP-63-mediated anchoring of theendoplasmic reticulum to microtubules."; Vedrenne C., Klopfenstein D.R., Hauri H.P.; Mol. Biol. Cell 16:1928-1937(2005). Cited for: FUNCTION IN CYTOSKELETON ANCHORING, AND PHOSPHORYLATION AT SER-3;SER-17 AND SER-19. | |